Invega Sustenna

Invega Sustenna Use In Pregnancy & Lactation



Johnson & Johnson


Full Prescribing Info
Use In Pregnancy & Lactation
Use in pregnancy: The safety of IM injected paliperidone palmitate for use during human pregnancy has not been established. No teratogenic effect was noted in any animal study.
Use in lactation: In animal studies with paliperidone and in human studies with risperidone, paliperidone was excreted in the milk. Therefore, women receiving Invega Sustenna should not breastfeed infants.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in